AIM
CDMO

Alambic Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Alambic Investment Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,500
Closed -$46K – 520
2017
Q3 		$46K Buy
+14,500
New +$54.5K 0.01% 480

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Alambic Investment Management's CDMO Position: Q4 2017 in Review

Alambic Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2017, closing a stake of 14,500 shares — an estimated $46K sold.

Alambic Investment Management first reported a position in CDMO in Q3 2017 and held it in 1 quarter. The position peaked at $46K in Q3 2017. 56 funds tracked by Wall St. Rank hold CDMO as of Q4 2017.

  • Alambic Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Alambic Investment Management sold 14,500 Avid Bioservices, Inc. Common Stock shares in Q4 2017, an estimated $46K.
  • Alambic Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Alambic Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $46K in Q3 2017.
  • 56 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2017.

Based on Alambic Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.